keyboard_arrow_up

Animal Antimicrobials and Antibiotics Market worth $4,143.8 Million by 2018

The report “Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018”, The market was valued at $3,340.8 million in 2013 and is expected to grow at a modest CAGR of 4.4% to reach $4,143.8 Million by 2018.

Browse 128 market data tables 40 figures spread through 274 pages and in-depth TOC on “Animal Antimicrobials and Antibiotics Market”
http://www.marketsandmarkets.com/Market-Reports/animal-antimicrobials-antibiotics-market-25161353.html
Early buyers will receive 10% customization on this report.

This report studies the global animal antimicrobials and antibiotics market, with forecast to 2018.

The animal antimicrobials and antibiotics market has experienced sluggish growth in the past few years, mainly due to the dearth of antibiotics in the pipeline of pharmaceutical companies, regulatory authorities of various nations banning the use of antibiotics, and increasing concerns about antibiotic resistances. Factors that are expected to propel the market growth include rise in demand for animal protein products, along with an increase in the trend of companion animal ownership especially in the emerging countries.

Talk to Our Research Analysts for More Info@
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=25161353

However, the regulatory ban posed by United States Food and Drug Administration (FDA) on the use of antibiotics, increased usage of in-feed enzymes, competitive exclusion products and probiotics as an alternative to antibiotics and prophylactic use of antibiotics being replaced by good husbandry, environment and hygienic practices are factors that inhibit the growth of the market to a certain extent.

In this report, the global animal antimicrobials and antibiotics market is segmented by product type, animals, mode of delivery, geography, and country. It also discusses the key market drivers, restraints, and opportunities of this market and its sub-markets. The market was valued at $3,340.8 million in 2013 and is expected to grow at a modest CAGR of 4.4% from 2013 to 2018.

North America was major market for global animal antimicrobials and antibiotics with a market share of around 28% to 30% of the global market, closely followed by Europe. Both of these regions namely, North America and Europe are experiencing sluggish growth in the animal antimicrobials and antibiotics market. Regulatory ban on usage of antibiotics, growing antibiotic resistance, dearth of new antibiotics in pharmaceutical companies pipeline are major factors curbing the growth of these markets.

Get The Sample Copy Of This Report:
http://www.marketsandmarkets.com/requestsample.asp?id=25161353

The major players in the animal antimicrobials and antibiotics market are Zoetis Inc. (U.S.), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Merial (U.S.), Bayer Animal Health (Germany), Virbac Animal Health (U.S.),  and CEVA Santé Animale (U.S.)., among others, among others.

Browse Related Reports:
Veterinary Diagnostics Market
by Products (Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging), by Animals (Companion, Food-producing, Dog, Livestock, Poultry, Swine) - Global Forecast to 2018.
http://www.marketsandmarkets.com/Market-Reports/veterinary-diagnostics-market-26017452.html

Animal Growth Promoters and Performance Enhancers Market by Segment (Antibiotics, Growth Hormones, Feed Enzymes, Organic Acids, Probiotics and Prebiotics, â-Agonists, Phytogenics), by Animals (Porcine, Poultry, Aquaculture) - Global Forecasts to 2018.
http://www.marketsandmarkets.com/Market-Reports/animal-growth-promoters-performance-enhancers-market-137134167.html

About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:
Mr. Rohan
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/pharmaceuticals
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets